Why Your Pre-Bed HGH Injection Is Built For The Wrong Body

Your body releases roughly 70 percent of its daily growth hormone in a single concentrated pulse during the deepest stage of sleep, somewhere between 11pm and 2am depending on when you went to bed, and that pulse is doing something specific that most people running exogenous HGH never account for.

To understand why timing your injection matters as much as it does, you need the full chain first.

Growth hormone doesn't build tissue directly. It travels to the liver, signals it to produce something called IGF-1, which is insulin-like growth factor 1, a hormone that actually enters your muscle cells and drives the anabolic effects you're after. So the sequence is: growth hormone goes up, liver converts it, IGF-1 goes up, tissue responds. The injection is just step one. What happens at the liver is where the outcome is actually decided, and the liver doesn't convert growth hormone in isolation. It converts it most efficiently when insulin is also present, because insulin and growth hormone act together at the liver to drive IGF-1 output. That cooperation is the window most people are missing.

Now here's where the pre-bed protocol breaks down.

When you inject subcutaneous HGH at 10pm, it doesn't peak immediately. Subcutaneous absorption is gradual, and pharmacokinetic data shows the concentration in your blood peaks roughly 4 hours after injection. That puts your exogenous peak at approximately 2am, landing directly on top of the natural pulse your pituitary is already producing. You haven't added a second pulse to a quiet window. You've stacked an artificial peak onto the one your body was generating anyway, which means part of what you injected is wasted signal competing with your own endogenous output rather than filling a gap where output was absent.

Growth hormone is also counter-regulatory, which means it works against insulin rather than with it. At the liver specifically, high growth hormone suppresses insulin sensitivity and blocks glucose uptake, pushing glucose back into circulation. This is the mechanism behind what researchers studying type 1 diabetics identified as the dawn phenomenon, where nocturnal spikes in growth hormone reduce hepatic insulin sensitivity in the early morning hours, causing fasting glucose to rise before the person even eats. When you add exogenous HGH on top of an already-high nighttime pulse, you're amplifying exactly that effect, and the consequence is what people describe when they say they wake up groggy with elevated blood glucose after a pre-bed injection.

The morning fasted window works differently for a specific reason.

When you wake up, your natural pulse has already fired and is declining. Growth hormone levels are falling back toward baseline. You inject fasted, and over the next 2 to 3 hours your exogenous HGH is climbing toward its peak. Then 30 to 60 minutes after the injection, you eat your first meal. That meal raises insulin. And what you've done is create a window where growth hormone and insulin are both elevated at the same time, hitting the liver together, which is the state that drives IGF-1 conversion most efficiently. You're not fighting the counter-regulatory effect because you're in a fed state, not a fasted overnight state where glucose has nowhere to go.

The pre-bed protocol comes from a 1990 study by Jorgensen and colleagues that compared evening versus morning injections in growth hormone deficient patients. The key detail that most people who cite this study don't include is who those patients were. They were individuals with complete pituitary failure, meaning no endogenous growth hormone production whatsoever. Their own gland had stopped working entirely. The researchers found that 24-hour IGF-1 levels came out essentially the same whether those patients injected in the morning or the evening. That result makes sense for that population, because with no natural pulse to protect or stack on top of, the timing of the single exogenous dose matters less. The liver is seeing growth hormone for the first time in either case.

But that finding was then carried over into protocols for people whose pituitaries are still functional, which is a completely different physiological situation.

If you are using HGH recreationally or for performance and your pituitary is still active, you have a natural pulse firing every night that is giving you roughly 70 percent of your daily growth hormone output for free. Pre-bed injection isn't protecting that pulse. It's competing with it, driving a glucose response you then wake up to, and landing your exogenous peak at a time when insulin is at its overnight low and IGF-1 conversion at the liver is least supported.

For doses at 4 IU or higher, splitting the dose handles the duration problem without sacrificing the morning conversion window. One injection fasted in the morning captures the liver's cooperative state with that first meal. A second injection in the late afternoon, typically around 3 to 5pm, extends IGF-1 output through the evening without pushing a peak into the overnight window where it disrupts the natural pulse or the metabolic state that produces it.

The dose split also keeps each injection's individual peak lower than a single large dose would, which reduces the magnitude of the counter-regulatory glucose response from any one injection.

The practical summary is this: inject fasted in the morning, eat 30 to 60 minutes later, and if you're running enough to warrant a second dose, put it in the mid-to-late afternoon. The pre-bed slot was designed for a body that had lost its own production entirely, and transplanting it into a body that's still producing means you're optimizing for a physiology that isn't yours.

The deeper point is that growth hormone doesn't work in isolation from the rest of your endocrine system. It works in a sequence that depends on what else is happening hormonally in the same window. The injection is only as useful as the conversion environment you've built around it.

---

References

1. Van Cauter E, Plat L. (1996). Physiology of growth hormone secretion during sleep. J Pediatr 128(5 Pt 2):S32-37. DOI: 10.1016/s0022-3476(96)70008-2
2. Jorgensen JO, Moller N, Moller J, Weeke J, Christiansen JS. (1985). Pharmacokinetics of biosynthetic authentic human growth hormone in normal men after subcutaneous or intramuscular injection. Acta Endocrinol (Copenh). PMID: 4034296
3. Jorgensen JO, Moller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS. (1990). Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 70(1):207-14. PMID: 2294131. DOI: 10.1210/jcem-70-1-207
4. Moller N, Jorgensen JO. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152-77. PMID: 19240267. DOI: 10.1210/er.2008-0027
5. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. (1990). Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33(1):52-9. PMID: 2406181. DOI: 10.1007/BF00586461

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness